Lilly’s retatrutide delivers 20.8% weight loss in phase 3 diabetes trial

Retatrutide is an investigational, first-in-class combination of GIP, GLP-1 and glucagon receptor activity

Acrotech Biopharma enters US dermatology market with ADQUEY launch

Novel, non-steroidal topical PDE4 inhibitor is approved for adults and pediatric patients aged 2 years and older

Novo Nordisk strikes up to $2.6 billion deal for Hengrui’s oral GLP-1 drug

The deal includes a $300 million upfront payment, with the remaining value tied to development, regulatory and commercial milestones

Biodeal Pharmaceuticals acquires major sterile injectable facility from Biological E

Biodeal also plans to add pre-filled syringe (PFS) and lyophilised formats

AstraZeneca bets $2 billion on Summit’s cancer drug in major ADC push

AstraZeneca will take a roughly 12% stake in Summit Therapeutics under a deal aimed at accelerating development of ivonescimab

Anupam Rasayan completes Rs. 1,750 crore acquisition of Bliss GVS Pharma to build global platform

The acquisition provides access to Bliss GVS Pharma’s established portfolio of branded formulations, manufacturing infrastructure and presence across multiple therapeutic segments

Anupam Rasayan to build Rs. 4,000+ crore integrated life sciences and CDMO platform

Acquired Tanfac Industries, Jayhawk Fine Chemicals and Bliss GVS Pharma in last 4 years

QMS Medical Allied Services to acquire BeamOptics Scientific

Steps up deep-tech product push

Merck strikes $2.13 billion deal for SciBrunch’s KRAS inhibitor

Under the agreement, SciBrunch will receive $400 million upfront and could collect additional payments tied to development

CRISIL forecasts 11–13% growth for Indian pharma sector in FY27

Export momentum to provide lift; cost pressures to trim margins by 150-200 bps

Wellness and prevention must drive India’s next healthcare push: Dr. Jitendra Singh

Singh also highlighted the role of science and technology in tackling emerging healthcare challenges

Novotech to acquire Agilex Biolabs expanding Australian bioanalytical Clcapabilities

Xenix Medical wins FDA clearance for Riva Anchor spinopelvic fixation system

The system combines a Riva Anchor SI joint fusion implant with the company’s Riva Posterior Pedicle Fixation System

Sun Pharma partners with LIB Therapeutics for global rights to newly EU-approved cholesterol drug Lyrokaul

Under the agreement, LIB Therapeutics will receive upfront and milestone payments, plus net sales royalties

Dr. Lal PathLabs acquires 80% stake in Ghana’s Sunshine Healthcare

The transaction was executed via Dr. Lal PathLabs FZCO

Briefs: Biocon Malaysia, IOL Chemicals and NATCO Pharma

Biocon Malaysia bags UK MHRA nod for new Insulin fill-finish line

Jagsonpal Pharma to acquire Group Pharma’s wellness portfolio for Rs. 46.7 Cr

Under the terms of the deal, Jagsonpal will pay an upfront initial consideration of Rs. 23.7 crore at closing

Briefs: Zydus Lifesciences and RPG Active Pharma

Zydus Lifesciences' New Jersey Office clears USFDA inspection with zero observations

NGL Fine Chem starts Phase II production at Tarapur

The company had earlier intimated that Phase I of the Greenfield facility commenced commercial production with effect from March 11, 2025

Briefs: IOL Chemicals and Pharmaceuticals and Dr. Lal PathLabs

IOL Chemicals and Pharmaceuticals obtains EU-REACH registration for Triacetin